A novel HSP90 inhibitor-drug conjugate to SN38 is highly effective in small cell lung cancerGaponova A.,
Nikonova A.,
Deneka A.,
Kopp M.,
Kudinov A.,
Skobeleva N.,
Khazak V.,
Ogawa L.,
Cai K.,
Duncan K.,
Duncan J.,
Egleston B.,
Proia D.,
Boumber Y.,
Golemis E. ©2016 AACR.Purpose:
Small cell lung cancer (SCLC) is a highly aggressive disease representing 12
Циркулирующие ДНК-маркеры при мониторинге рака легкого: анализ статуса метилирования ретроэлементов LINE-1 and at the stages of dynamic observation after antitumor therapy. The study included 16 patients with
non-small cell